Disordered lipid nanoparticles deliver mRNA more effectively than tightly packed ones, a new study finds.

Fabtech wins ₹63.6 crore contract to build a GMP-compliant pharma plant in West Africa, boosting local medicine production.

AstraZeneca blocked Pharmacor’s generic diabetes drug launch in Australia with a court order, protecting its patent until a full trial.

Doctyn Academy in New Delhi expanded medical training for doctors to boost clinical skills and patient care through hands-on, real-world practice.

UAE launches Jaheziya, a national medical readiness system enhancing emergency response through simulation and training.

A new AI tool predicts deadly transplant complications months in advance, helping doctors act sooner.

India's medical tourism boom sees Ahmedabad's Musk Clinic draw global patients with AI-powered, FDA-approved hair transplants.

Indian generic drug maker Natco gains 11% after FDA approval for diabetes drug, amid regulatory updates and profit rise.

Cellectis, a Paris-based biotech developing gene-edited cancer therapies, received a "Moderate Buy" rating with a $6.33 average 12-month target.

A new minimally invasive heart procedure is now available in Palm Beach County, offering faster recovery and lower risks for patients with severe blockages.